GOLDEN VALLEY, Minn.–(BUSINESS WIRE)–Preceptis Medical, Inc., a pioneer in pediatric ENT innovation, today announced the publication…
Continue ReadingTag: significantly
Nimotuzumab can significantly increase the chances of survival in head and neck cancer, Tata Memorial study finds – Healthcare News
Adding Nimotuzumab to the standard treatment regimen significantly improves the 10-year overall survival rate for patients…
Continue Reading